Wolverine Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
6,293
-607
| -9% | -$22.2K | ﹤0.01% | 937 |
|
|
2025
Q1 | $261K | Buy |
+6,900
| New | +$261K | ﹤0.01% | 946 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2218 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2068 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2003 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1976 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1984 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1946 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1912 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1894 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2357 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2477 |
|
|
2021
Q3 | – | Sell |
-2,104
| Closed | -$203K | – | 2532 |
|
|
2021
Q2 | $203K | Buy |
+2,104
| New | +$203K | ﹤0.01% | 1475 |
|
|
2020
Q3 | – | Sell |
-4,585
| Closed | -$338K | – | 1853 |
|
|
2020
Q2 | $338K | Buy |
+4,585
| New | +$338K | ﹤0.01% | 766 |
|